Global Burn and Scald Medicine Market Research Report 2026(Status and Outlook)
Burns are a common traumatic disease caused by physical or chemical factors, such as heat, chemistry, electric current and radiation. Small-area burns only cause damage to the skin and (or) mucosal tissue or the corresponding deep tissue. However, larger-area burns can cause functional, metabolic and morphological changes in various systems of the body to varying degrees, causing severe systemic reactions and visceral damage in the injured, and complications such as shock, sepsis and multiple organ failure, with a high mortality rate. The healing and treatment process of burn wounds is complex and takes a long time. After the wound heals, sequelae such as scar contracture and functional impairment may remain. Therefore, burns, especially large-area burns, are the most complex and serious traumatic diseases. In order to treat patients with large-area severe burns, in addition to the need for specialists to have solid basic medical knowledge and experience in burns, other departments such as general surgery, cardiothoracic surgery, urology, orthopedics, anesthesiology and internal medicine need to work together for consultation and treatment to form a team to achieve success. This is the result of collective efforts, cooperation and collaborative work. Burn and scald medicines refer to medicines used to treat skin or tissue damage caused by heat (such as flames, hot water, steam), chemicals, electric current or radiation. The main functions of these medicines are to relieve pain, prevent infection, promote wound healing and reduce scar formation. According to the severity and type of burns, burn and scald medicines can be divided into topical medicines, oral medicines and new therapies. The statistical object of this article is topical medicines for burns and scalds.
The global Burn and Scald Medicine market size was estimated at USD 454.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Burn and Scald Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Burn and Scald Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Burn and Scald Medicine market.
Global Burn and Scald Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Mebao Pharmaceutical Technology Group
B. Braun
Integra LifeSciences
Jinyao Darentang
Smith & Nephew
Yangtze River Pharmaceutical Group
STADA Thornton & Ross
Kenvue Brands LLC
Changchun Overseas Pharmaceutical Group Co., Ltd.
Orkla Health
Guangdong Hengjian Pharmaceutical
Otsuka Pharmaceutical Co., Ltd.
Tonghua Maoxiang Pharmaceutical Co., Ltd.
Cipla
Tanabe Mitsubishi Pharmaceuticals
Chongqing Xixuan Biotechnology Co., Ltd.
Quest Products, LLC
Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
Acme United Corp.
Dongwha Pharm
China Resources Pharmaceutical Group
Safetec Of America
Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo
Xiangxi Hongcheng Pharmaceutical
Hebei Aoxing Group Pharmaceuticals
Jilin Aodong Pharmaceutical Group
Beijing Tongrentang
Henan Quanyu Pharmaceuticals
Chengdu First Pharmaceuticals
Market Segmentation (by Type)
Ointment
Spray
Oil
Other
Market Segmentation (by Application)
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Burn and Scald Medicine Market
Overview of the regional outlook of the Burn and Scald Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Burn and Scald Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Burn and Scald Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Burn and Scald Medicine market size was estimated at USD 454.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Burn and Scald Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Burn and Scald Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Burn and Scald Medicine market.
Global Burn and Scald Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Mebao Pharmaceutical Technology Group
B. Braun
Integra LifeSciences
Jinyao Darentang
Smith & Nephew
Yangtze River Pharmaceutical Group
STADA Thornton & Ross
Kenvue Brands LLC
Changchun Overseas Pharmaceutical Group Co., Ltd.
Orkla Health
Guangdong Hengjian Pharmaceutical
Otsuka Pharmaceutical Co., Ltd.
Tonghua Maoxiang Pharmaceutical Co., Ltd.
Cipla
Tanabe Mitsubishi Pharmaceuticals
Chongqing Xixuan Biotechnology Co., Ltd.
Quest Products, LLC
Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
Acme United Corp.
Dongwha Pharm
China Resources Pharmaceutical Group
Safetec Of America
Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo
Xiangxi Hongcheng Pharmaceutical
Hebei Aoxing Group Pharmaceuticals
Jilin Aodong Pharmaceutical Group
Beijing Tongrentang
Henan Quanyu Pharmaceuticals
Chengdu First Pharmaceuticals
Market Segmentation (by Type)
Ointment
Spray
Oil
Other
Market Segmentation (by Application)
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Burn and Scald Medicine Market
Overview of the regional outlook of the Burn and Scald Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Burn and Scald Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Burn and Scald Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Burn and Scald Medicine
1.2 Key Market Segments
1.2.1 Burn and Scald Medicine Segment by Type
1.2.2 Burn and Scald Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BURN AND SCALD MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Burn and Scald Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Burn and Scald Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BURN AND SCALD MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Burn and Scald Medicine Product Life Cycle
3.3 Global Burn and Scald Medicine Sales by Manufacturers (2020-2025)
3.4 Global Burn and Scald Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Burn and Scald Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Burn and Scald Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Burn and Scald Medicine Market Competitive Situation and Trends
3.8.1 Burn and Scald Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Burn and Scald Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BURN AND SCALD MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Burn and Scald Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BURN AND SCALD MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Burn and Scald Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Burn and Scald Medicine Market
5.7 ESG Ratings of Leading Companies
6 BURN AND SCALD MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Burn and Scald Medicine Sales Market Share by Type (2020-2025)
6.3 Global Burn and Scald Medicine Market Size by Type (2020-2025)
6.4 Global Burn and Scald Medicine Price by Type (2020-2025)
7 BURN AND SCALD MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Burn and Scald Medicine Market Sales by Application (2020-2025)
7.3 Global Burn and Scald Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Burn and Scald Medicine Sales Growth Rate by Application (2020-2025)
8 BURN AND SCALD MEDICINE MARKET SALES BY REGION
8.1 Global Burn and Scald Medicine Sales by Region
8.1.1 Global Burn and Scald Medicine Sales by Region
8.1.2 Global Burn and Scald Medicine Sales Market Share by Region
8.2 Global Burn and Scald Medicine Market Size by Region
8.2.1 Global Burn and Scald Medicine Market Size by Region
8.2.2 Global Burn and Scald Medicine Market Size by Region
8.3 North America
8.3.1 North America Burn and Scald Medicine Sales by Country
8.3.2 North America Burn and Scald Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Burn and Scald Medicine Sales by Country
8.4.2 Europe Burn and Scald Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Burn and Scald Medicine Sales by Region
8.5.2 Asia Pacific Burn and Scald Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Burn and Scald Medicine Sales by Country
8.6.2 South America Burn and Scald Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Burn and Scald Medicine Sales by Region
8.7.2 Middle East and Africa Burn and Scald Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BURN AND SCALD MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Burn and Scald Medicine by Region(2020-2025)
9.2 Global Burn and Scald Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Burn and Scald Medicine Production
9.4.1 North America Burn and Scald Medicine Production Growth Rate (2020-2025)
9.4.2 North America Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Burn and Scald Medicine Production
9.5.1 Europe Burn and Scald Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Burn and Scald Medicine Production (2020-2025)
9.6.1 Japan Burn and Scald Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Burn and Scald Medicine Production (2020-2025)
9.7.1 China Burn and Scald Medicine Production Growth Rate (2020-2025)
9.7.2 China Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Mebao Pharmaceutical Technology Group
10.1.1 Mebao Pharmaceutical Technology Group Basic Information
10.1.2 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Overview
10.1.3 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Market Performance
10.1.4 Mebao Pharmaceutical Technology Group Business Overview
10.1.5 Mebao Pharmaceutical Technology Group SWOT Analysis
10.1.6 Mebao Pharmaceutical Technology Group Recent Developments
10.2 B. Braun
10.2.1 B. Braun Basic Information
10.2.2 B. Braun Burn and Scald Medicine Product Overview
10.2.3 B. Braun Burn and Scald Medicine Product Market Performance
10.2.4 B. Braun Business Overview
10.2.5 B. Braun SWOT Analysis
10.2.6 B. Braun Recent Developments
10.3 Integra LifeSciences
10.3.1 Integra LifeSciences Basic Information
10.3.2 Integra LifeSciences Burn and Scald Medicine Product Overview
10.3.3 Integra LifeSciences Burn and Scald Medicine Product Market Performance
10.3.4 Integra LifeSciences Business Overview
10.3.5 Integra LifeSciences SWOT Analysis
10.3.6 Integra LifeSciences Recent Developments
10.4 Jinyao Darentang
10.4.1 Jinyao Darentang Basic Information
10.4.2 Jinyao Darentang Burn and Scald Medicine Product Overview
10.4.3 Jinyao Darentang Burn and Scald Medicine Product Market Performance
10.4.4 Jinyao Darentang Business Overview
10.4.5 Jinyao Darentang Recent Developments
10.5 Smith and Nephew
10.5.1 Smith and Nephew Basic Information
10.5.2 Smith and Nephew Burn and Scald Medicine Product Overview
10.5.3 Smith and Nephew Burn and Scald Medicine Product Market Performance
10.5.4 Smith and Nephew Business Overview
10.5.5 Smith and Nephew Recent Developments
10.6 Yangtze River Pharmaceutical Group
10.6.1 Yangtze River Pharmaceutical Group Basic Information
10.6.2 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Overview
10.6.3 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Market Performance
10.6.4 Yangtze River Pharmaceutical Group Business Overview
10.6.5 Yangtze River Pharmaceutical Group Recent Developments
10.7 STADA Thornton and Ross
10.7.1 STADA Thornton and Ross Basic Information
10.7.2 STADA Thornton and Ross Burn and Scald Medicine Product Overview
10.7.3 STADA Thornton and Ross Burn and Scald Medicine Product Market Performance
10.7.4 STADA Thornton and Ross Business Overview
10.7.5 STADA Thornton and Ross Recent Developments
10.8 Kenvue Brands LLC
10.8.1 Kenvue Brands LLC Basic Information
10.8.2 Kenvue Brands LLC Burn and Scald Medicine Product Overview
10.8.3 Kenvue Brands LLC Burn and Scald Medicine Product Market Performance
10.8.4 Kenvue Brands LLC Business Overview
10.8.5 Kenvue Brands LLC Recent Developments
10.9 Changchun Overseas Pharmaceutical Group Co., Ltd.
10.9.1 Changchun Overseas Pharmaceutical Group Co., Ltd. Basic Information
10.9.2 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Overview
10.9.3 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Market Performance
10.9.4 Changchun Overseas Pharmaceutical Group Co., Ltd. Business Overview
10.9.5 Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments
10.10 Orkla Health
10.10.1 Orkla Health Basic Information
10.10.2 Orkla Health Burn and Scald Medicine Product Overview
10.10.3 Orkla Health Burn and Scald Medicine Product Market Performance
10.10.4 Orkla Health Business Overview
10.10.5 Orkla Health Recent Developments
10.11 Guangdong Hengjian Pharmaceutical
10.11.1 Guangdong Hengjian Pharmaceutical Basic Information
10.11.2 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Overview
10.11.3 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Market Performance
10.11.4 Guangdong Hengjian Pharmaceutical Business Overview
10.11.5 Guangdong Hengjian Pharmaceutical Recent Developments
10.12 Otsuka Pharmaceutical Co., Ltd.
10.12.1 Otsuka Pharmaceutical Co., Ltd. Basic Information
10.12.2 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
10.12.3 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Market Performance
10.12.4 Otsuka Pharmaceutical Co., Ltd. Business Overview
10.12.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
10.13 Tonghua Maoxiang Pharmaceutical Co., Ltd.
10.13.1 Tonghua Maoxiang Pharmaceutical Co., Ltd. Basic Information
10.13.2 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
10.13.3 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Market Performance
10.13.4 Tonghua Maoxiang Pharmaceutical Co., Ltd. Business Overview
10.13.5 Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments
10.14 Cipla
10.14.1 Cipla Basic Information
10.14.2 Cipla Burn and Scald Medicine Product Overview
10.14.3 Cipla Burn and Scald Medicine Product Market Performance
10.14.4 Cipla Business Overview
10.14.5 Cipla Recent Developments
10.15 Tanabe Mitsubishi Pharmaceuticals
10.15.1 Tanabe Mitsubishi Pharmaceuticals Basic Information
10.15.2 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Overview
10.15.3 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.15.4 Tanabe Mitsubishi Pharmaceuticals Business Overview
10.15.5 Tanabe Mitsubishi Pharmaceuticals Recent Developments
10.16 Chongqing Xixuan Biotechnology Co., Ltd.
10.16.1 Chongqing Xixuan Biotechnology Co., Ltd. Basic Information
10.16.2 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Overview
10.16.3 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Market Performance
10.16.4 Chongqing Xixuan Biotechnology Co., Ltd. Business Overview
10.16.5 Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments
10.17 Quest Products, LLC
10.17.1 Quest Products, LLC Basic Information
10.17.2 Quest Products, LLC Burn and Scald Medicine Product Overview
10.17.3 Quest Products, LLC Burn and Scald Medicine Product Market Performance
10.17.4 Quest Products, LLC Business Overview
10.17.5 Quest Products, LLC Recent Developments
10.18 Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
10.18.1 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Basic Information
10.18.2 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Overview
10.18.3 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Market Performance
10.18.4 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Business Overview
10.18.5 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments
10.19 Acme United Corp.
10.19.1 Acme United Corp. Basic Information
10.19.2 Acme United Corp. Burn and Scald Medicine Product Overview
10.19.3 Acme United Corp. Burn and Scald Medicine Product Market Performance
10.19.4 Acme United Corp. Business Overview
10.19.5 Acme United Corp. Recent Developments
10.20 Dongwha Pharm
10.20.1 Dongwha Pharm Basic Information
10.20.2 Dongwha Pharm Burn and Scald Medicine Product Overview
10.20.3 Dongwha Pharm Burn and Scald Medicine Product Market Performance
10.20.4 Dongwha Pharm Business Overview
10.20.5 Dongwha Pharm Recent Developments
10.21 China Resources Pharmaceutical Group
10.21.1 China Resources Pharmaceutical Group Basic Information
10.21.2 China Resources Pharmaceutical Group Burn and Scald Medicine Product Overview
10.21.3 China Resources Pharmaceutical Group Burn and Scald Medicine Product Market Performance
10.21.4 China Resources Pharmaceutical Group Business Overview
10.21.5 China Resources Pharmaceutical Group Recent Developments
10.22 Safetec Of America
10.22.1 Safetec Of America Basic Information
10.22.2 Safetec Of America Burn and Scald Medicine Product Overview
10.22.3 Safetec Of America Burn and Scald Medicine Product Market Performance
10.22.4 Safetec Of America Business Overview
10.22.5 Safetec Of America Recent Developments
10.23 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
10.23.1 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Basic Information
10.23.2 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
10.23.3 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Market Performance
10.23.4 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Business Overview
10.23.5 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments
10.24 North China Pharmaceutical Hebei Huanuo
10.24.1 North China Pharmaceutical Hebei Huanuo Basic Information
10.24.2 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Overview
10.24.3 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Market Performance
10.24.4 North China Pharmaceutical Hebei Huanuo Business Overview
10.24.5 North China Pharmaceutical Hebei Huanuo Recent Developments
10.25 Xiangxi Hongcheng Pharmaceutical
10.25.1 Xiangxi Hongcheng Pharmaceutical Basic Information
10.25.2 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Overview
10.25.3 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Market Performance
10.25.4 Xiangxi Hongcheng Pharmaceutical Business Overview
10.25.5 Xiangxi Hongcheng Pharmaceutical Recent Developments
10.26 Hebei Aoxing Group Pharmaceuticals
10.26.1 Hebei Aoxing Group Pharmaceuticals Basic Information
10.26.2 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Overview
10.26.3 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.26.4 Hebei Aoxing Group Pharmaceuticals Business Overview
10.26.5 Hebei Aoxing Group Pharmaceuticals Recent Developments
10.27 Jilin Aodong Pharmaceutical Group
10.27.1 Jilin Aodong Pharmaceutical Group Basic Information
10.27.2 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Overview
10.27.3 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Market Performance
10.27.4 Jilin Aodong Pharmaceutical Group Business Overview
10.27.5 Jilin Aodong Pharmaceutical Group Recent Developments
10.28 Beijing Tongrentang
10.28.1 Beijing Tongrentang Basic Information
10.28.2 Beijing Tongrentang Burn and Scald Medicine Product Overview
10.28.3 Beijing Tongrentang Burn and Scald Medicine Product Market Performance
10.28.4 Beijing Tongrentang Business Overview
10.28.5 Beijing Tongrentang Recent Developments
10.29 Henan Quanyu Pharmaceuticals
10.29.1 Henan Quanyu Pharmaceuticals Basic Information
10.29.2 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Overview
10.29.3 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.29.4 Henan Quanyu Pharmaceuticals Business Overview
10.29.5 Henan Quanyu Pharmaceuticals Recent Developments
10.30 Chengdu First Pharmaceuticals
10.30.1 Chengdu First Pharmaceuticals Basic Information
10.30.2 Chengdu First Pharmaceuticals Burn and Scald Medicine Product Overview
10.30.3 Chengdu First Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.30.4 Chengdu First Pharmaceuticals Business Overview
10.30.5 Chengdu First Pharmaceuticals Recent Developments
11 BURN AND SCALD MEDICINE MARKET FORECAST BY REGION
11.1 Global Burn and Scald Medicine Market Size Forecast
11.2 Global Burn and Scald Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Burn and Scald Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Burn and Scald Medicine Market Size Forecast by Region
11.2.4 South America Burn and Scald Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Burn and Scald Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Burn and Scald Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Burn and Scald Medicine by Type (2026-2035)
12.1.2 Global Burn and Scald Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Burn and Scald Medicine by Type (2026-2035)
12.2 Global Burn and Scald Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Burn and Scald Medicine Sales (K MT) Forecast by Application
12.2.2 Global Burn and Scald Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Burn and Scald Medicine
1.2 Key Market Segments
1.2.1 Burn and Scald Medicine Segment by Type
1.2.2 Burn and Scald Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BURN AND SCALD MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Burn and Scald Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Burn and Scald Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BURN AND SCALD MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Burn and Scald Medicine Product Life Cycle
3.3 Global Burn and Scald Medicine Sales by Manufacturers (2020-2025)
3.4 Global Burn and Scald Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Burn and Scald Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Burn and Scald Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Burn and Scald Medicine Market Competitive Situation and Trends
3.8.1 Burn and Scald Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Burn and Scald Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BURN AND SCALD MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Burn and Scald Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BURN AND SCALD MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Burn and Scald Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Burn and Scald Medicine Market
5.7 ESG Ratings of Leading Companies
6 BURN AND SCALD MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Burn and Scald Medicine Sales Market Share by Type (2020-2025)
6.3 Global Burn and Scald Medicine Market Size by Type (2020-2025)
6.4 Global Burn and Scald Medicine Price by Type (2020-2025)
7 BURN AND SCALD MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Burn and Scald Medicine Market Sales by Application (2020-2025)
7.3 Global Burn and Scald Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Burn and Scald Medicine Sales Growth Rate by Application (2020-2025)
8 BURN AND SCALD MEDICINE MARKET SALES BY REGION
8.1 Global Burn and Scald Medicine Sales by Region
8.1.1 Global Burn and Scald Medicine Sales by Region
8.1.2 Global Burn and Scald Medicine Sales Market Share by Region
8.2 Global Burn and Scald Medicine Market Size by Region
8.2.1 Global Burn and Scald Medicine Market Size by Region
8.2.2 Global Burn and Scald Medicine Market Size by Region
8.3 North America
8.3.1 North America Burn and Scald Medicine Sales by Country
8.3.2 North America Burn and Scald Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Burn and Scald Medicine Sales by Country
8.4.2 Europe Burn and Scald Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Burn and Scald Medicine Sales by Region
8.5.2 Asia Pacific Burn and Scald Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Burn and Scald Medicine Sales by Country
8.6.2 South America Burn and Scald Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Burn and Scald Medicine Sales by Region
8.7.2 Middle East and Africa Burn and Scald Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BURN AND SCALD MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Burn and Scald Medicine by Region(2020-2025)
9.2 Global Burn and Scald Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Burn and Scald Medicine Production
9.4.1 North America Burn and Scald Medicine Production Growth Rate (2020-2025)
9.4.2 North America Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Burn and Scald Medicine Production
9.5.1 Europe Burn and Scald Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Burn and Scald Medicine Production (2020-2025)
9.6.1 Japan Burn and Scald Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Burn and Scald Medicine Production (2020-2025)
9.7.1 China Burn and Scald Medicine Production Growth Rate (2020-2025)
9.7.2 China Burn and Scald Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Mebao Pharmaceutical Technology Group
10.1.1 Mebao Pharmaceutical Technology Group Basic Information
10.1.2 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Overview
10.1.3 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Market Performance
10.1.4 Mebao Pharmaceutical Technology Group Business Overview
10.1.5 Mebao Pharmaceutical Technology Group SWOT Analysis
10.1.6 Mebao Pharmaceutical Technology Group Recent Developments
10.2 B. Braun
10.2.1 B. Braun Basic Information
10.2.2 B. Braun Burn and Scald Medicine Product Overview
10.2.3 B. Braun Burn and Scald Medicine Product Market Performance
10.2.4 B. Braun Business Overview
10.2.5 B. Braun SWOT Analysis
10.2.6 B. Braun Recent Developments
10.3 Integra LifeSciences
10.3.1 Integra LifeSciences Basic Information
10.3.2 Integra LifeSciences Burn and Scald Medicine Product Overview
10.3.3 Integra LifeSciences Burn and Scald Medicine Product Market Performance
10.3.4 Integra LifeSciences Business Overview
10.3.5 Integra LifeSciences SWOT Analysis
10.3.6 Integra LifeSciences Recent Developments
10.4 Jinyao Darentang
10.4.1 Jinyao Darentang Basic Information
10.4.2 Jinyao Darentang Burn and Scald Medicine Product Overview
10.4.3 Jinyao Darentang Burn and Scald Medicine Product Market Performance
10.4.4 Jinyao Darentang Business Overview
10.4.5 Jinyao Darentang Recent Developments
10.5 Smith and Nephew
10.5.1 Smith and Nephew Basic Information
10.5.2 Smith and Nephew Burn and Scald Medicine Product Overview
10.5.3 Smith and Nephew Burn and Scald Medicine Product Market Performance
10.5.4 Smith and Nephew Business Overview
10.5.5 Smith and Nephew Recent Developments
10.6 Yangtze River Pharmaceutical Group
10.6.1 Yangtze River Pharmaceutical Group Basic Information
10.6.2 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Overview
10.6.3 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Market Performance
10.6.4 Yangtze River Pharmaceutical Group Business Overview
10.6.5 Yangtze River Pharmaceutical Group Recent Developments
10.7 STADA Thornton and Ross
10.7.1 STADA Thornton and Ross Basic Information
10.7.2 STADA Thornton and Ross Burn and Scald Medicine Product Overview
10.7.3 STADA Thornton and Ross Burn and Scald Medicine Product Market Performance
10.7.4 STADA Thornton and Ross Business Overview
10.7.5 STADA Thornton and Ross Recent Developments
10.8 Kenvue Brands LLC
10.8.1 Kenvue Brands LLC Basic Information
10.8.2 Kenvue Brands LLC Burn and Scald Medicine Product Overview
10.8.3 Kenvue Brands LLC Burn and Scald Medicine Product Market Performance
10.8.4 Kenvue Brands LLC Business Overview
10.8.5 Kenvue Brands LLC Recent Developments
10.9 Changchun Overseas Pharmaceutical Group Co., Ltd.
10.9.1 Changchun Overseas Pharmaceutical Group Co., Ltd. Basic Information
10.9.2 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Overview
10.9.3 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Market Performance
10.9.4 Changchun Overseas Pharmaceutical Group Co., Ltd. Business Overview
10.9.5 Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments
10.10 Orkla Health
10.10.1 Orkla Health Basic Information
10.10.2 Orkla Health Burn and Scald Medicine Product Overview
10.10.3 Orkla Health Burn and Scald Medicine Product Market Performance
10.10.4 Orkla Health Business Overview
10.10.5 Orkla Health Recent Developments
10.11 Guangdong Hengjian Pharmaceutical
10.11.1 Guangdong Hengjian Pharmaceutical Basic Information
10.11.2 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Overview
10.11.3 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Market Performance
10.11.4 Guangdong Hengjian Pharmaceutical Business Overview
10.11.5 Guangdong Hengjian Pharmaceutical Recent Developments
10.12 Otsuka Pharmaceutical Co., Ltd.
10.12.1 Otsuka Pharmaceutical Co., Ltd. Basic Information
10.12.2 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
10.12.3 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Market Performance
10.12.4 Otsuka Pharmaceutical Co., Ltd. Business Overview
10.12.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
10.13 Tonghua Maoxiang Pharmaceutical Co., Ltd.
10.13.1 Tonghua Maoxiang Pharmaceutical Co., Ltd. Basic Information
10.13.2 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
10.13.3 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Market Performance
10.13.4 Tonghua Maoxiang Pharmaceutical Co., Ltd. Business Overview
10.13.5 Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments
10.14 Cipla
10.14.1 Cipla Basic Information
10.14.2 Cipla Burn and Scald Medicine Product Overview
10.14.3 Cipla Burn and Scald Medicine Product Market Performance
10.14.4 Cipla Business Overview
10.14.5 Cipla Recent Developments
10.15 Tanabe Mitsubishi Pharmaceuticals
10.15.1 Tanabe Mitsubishi Pharmaceuticals Basic Information
10.15.2 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Overview
10.15.3 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.15.4 Tanabe Mitsubishi Pharmaceuticals Business Overview
10.15.5 Tanabe Mitsubishi Pharmaceuticals Recent Developments
10.16 Chongqing Xixuan Biotechnology Co., Ltd.
10.16.1 Chongqing Xixuan Biotechnology Co., Ltd. Basic Information
10.16.2 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Overview
10.16.3 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Market Performance
10.16.4 Chongqing Xixuan Biotechnology Co., Ltd. Business Overview
10.16.5 Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments
10.17 Quest Products, LLC
10.17.1 Quest Products, LLC Basic Information
10.17.2 Quest Products, LLC Burn and Scald Medicine Product Overview
10.17.3 Quest Products, LLC Burn and Scald Medicine Product Market Performance
10.17.4 Quest Products, LLC Business Overview
10.17.5 Quest Products, LLC Recent Developments
10.18 Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
10.18.1 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Basic Information
10.18.2 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Overview
10.18.3 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Market Performance
10.18.4 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Business Overview
10.18.5 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments
10.19 Acme United Corp.
10.19.1 Acme United Corp. Basic Information
10.19.2 Acme United Corp. Burn and Scald Medicine Product Overview
10.19.3 Acme United Corp. Burn and Scald Medicine Product Market Performance
10.19.4 Acme United Corp. Business Overview
10.19.5 Acme United Corp. Recent Developments
10.20 Dongwha Pharm
10.20.1 Dongwha Pharm Basic Information
10.20.2 Dongwha Pharm Burn and Scald Medicine Product Overview
10.20.3 Dongwha Pharm Burn and Scald Medicine Product Market Performance
10.20.4 Dongwha Pharm Business Overview
10.20.5 Dongwha Pharm Recent Developments
10.21 China Resources Pharmaceutical Group
10.21.1 China Resources Pharmaceutical Group Basic Information
10.21.2 China Resources Pharmaceutical Group Burn and Scald Medicine Product Overview
10.21.3 China Resources Pharmaceutical Group Burn and Scald Medicine Product Market Performance
10.21.4 China Resources Pharmaceutical Group Business Overview
10.21.5 China Resources Pharmaceutical Group Recent Developments
10.22 Safetec Of America
10.22.1 Safetec Of America Basic Information
10.22.2 Safetec Of America Burn and Scald Medicine Product Overview
10.22.3 Safetec Of America Burn and Scald Medicine Product Market Performance
10.22.4 Safetec Of America Business Overview
10.22.5 Safetec Of America Recent Developments
10.23 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
10.23.1 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Basic Information
10.23.2 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
10.23.3 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Market Performance
10.23.4 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Business Overview
10.23.5 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments
10.24 North China Pharmaceutical Hebei Huanuo
10.24.1 North China Pharmaceutical Hebei Huanuo Basic Information
10.24.2 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Overview
10.24.3 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Market Performance
10.24.4 North China Pharmaceutical Hebei Huanuo Business Overview
10.24.5 North China Pharmaceutical Hebei Huanuo Recent Developments
10.25 Xiangxi Hongcheng Pharmaceutical
10.25.1 Xiangxi Hongcheng Pharmaceutical Basic Information
10.25.2 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Overview
10.25.3 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Market Performance
10.25.4 Xiangxi Hongcheng Pharmaceutical Business Overview
10.25.5 Xiangxi Hongcheng Pharmaceutical Recent Developments
10.26 Hebei Aoxing Group Pharmaceuticals
10.26.1 Hebei Aoxing Group Pharmaceuticals Basic Information
10.26.2 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Overview
10.26.3 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.26.4 Hebei Aoxing Group Pharmaceuticals Business Overview
10.26.5 Hebei Aoxing Group Pharmaceuticals Recent Developments
10.27 Jilin Aodong Pharmaceutical Group
10.27.1 Jilin Aodong Pharmaceutical Group Basic Information
10.27.2 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Overview
10.27.3 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Market Performance
10.27.4 Jilin Aodong Pharmaceutical Group Business Overview
10.27.5 Jilin Aodong Pharmaceutical Group Recent Developments
10.28 Beijing Tongrentang
10.28.1 Beijing Tongrentang Basic Information
10.28.2 Beijing Tongrentang Burn and Scald Medicine Product Overview
10.28.3 Beijing Tongrentang Burn and Scald Medicine Product Market Performance
10.28.4 Beijing Tongrentang Business Overview
10.28.5 Beijing Tongrentang Recent Developments
10.29 Henan Quanyu Pharmaceuticals
10.29.1 Henan Quanyu Pharmaceuticals Basic Information
10.29.2 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Overview
10.29.3 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.29.4 Henan Quanyu Pharmaceuticals Business Overview
10.29.5 Henan Quanyu Pharmaceuticals Recent Developments
10.30 Chengdu First Pharmaceuticals
10.30.1 Chengdu First Pharmaceuticals Basic Information
10.30.2 Chengdu First Pharmaceuticals Burn and Scald Medicine Product Overview
10.30.3 Chengdu First Pharmaceuticals Burn and Scald Medicine Product Market Performance
10.30.4 Chengdu First Pharmaceuticals Business Overview
10.30.5 Chengdu First Pharmaceuticals Recent Developments
11 BURN AND SCALD MEDICINE MARKET FORECAST BY REGION
11.1 Global Burn and Scald Medicine Market Size Forecast
11.2 Global Burn and Scald Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Burn and Scald Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Burn and Scald Medicine Market Size Forecast by Region
11.2.4 South America Burn and Scald Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Burn and Scald Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Burn and Scald Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Burn and Scald Medicine by Type (2026-2035)
12.1.2 Global Burn and Scald Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Burn and Scald Medicine by Type (2026-2035)
12.2 Global Burn and Scald Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Burn and Scald Medicine Sales (K MT) Forecast by Application
12.2.2 Global Burn and Scald Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Burn and Scald Medicine Market Size by Type (M USD)
Table 4. Global Burn and Scald Medicine Market Size by Application
Table 5. Burn and Scald Medicine Market Size Comparison by Region (M USD)
Table 6. Global Burn and Scald Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Burn and Scald Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Burn and Scald Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Burn and Scald Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burn and Scald Medicine as of 2025)
Table 11. Global Market Burn and Scald Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Burn and Scald Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Burn and Scald Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Burn and Scald Medicine Sales by Type (K MT)
Table 27. Global Burn and Scald Medicine Market Size by Type (M USD)
Table 28. Global Burn and Scald Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Burn and Scald Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Burn and Scald Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Burn and Scald Medicine Market Share by Type (2020-2025)
Table 32. Global Burn and Scald Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Burn and Scald Medicine Sales (K MT) by Application
Table 34. Global Burn and Scald Medicine Market Size by Application
Table 35. Global Burn and Scald Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Burn and Scald Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Burn and Scald Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Burn and Scald Medicine Market Share by Application (2020-2025)
Table 39. Global Burn and Scald Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Burn and Scald Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Burn and Scald Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Burn and Scald Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Burn and Scald Medicine Market Size by Region (2020-2025)
Table 44. North America Burn and Scald Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Burn and Scald Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Burn and Scald Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Burn and Scald Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Burn and Scald Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Burn and Scald Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Burn and Scald Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Burn and Scald Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Burn and Scald Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Burn and Scald Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Burn and Scald Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Burn and Scald Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Burn and Scald Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Mebao Pharmaceutical Technology Group Basic Information
Table 63. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Overview
Table 64. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Mebao Pharmaceutical Technology Group Business Overview
Table 66. Mebao Pharmaceutical Technology Group SWOT Analysis
Table 67. Mebao Pharmaceutical Technology Group Recent Developments
Table 68. B. Braun Basic Information
Table 69. B. Braun Burn and Scald Medicine Product Overview
Table 70. B. Braun Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. B. Braun Business Overview
Table 72. B. Braun SWOT Analysis
Table 73. B. Braun Recent Developments
Table 74. Integra LifeSciences Basic Information
Table 75. Integra LifeSciences Burn and Scald Medicine Product Overview
Table 76. Integra LifeSciences Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Integra LifeSciences Business Overview
Table 78. Integra LifeSciences SWOT Analysis
Table 79. Integra LifeSciences Recent Developments
Table 80. Jinyao Darentang Basic Information
Table 81. Jinyao Darentang Burn and Scald Medicine Product Overview
Table 82. Jinyao Darentang Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Jinyao Darentang Business Overview
Table 84. Jinyao Darentang Recent Developments
Table 85. Smith and Nephew Basic Information
Table 86. Smith and Nephew Burn and Scald Medicine Product Overview
Table 87. Smith and Nephew Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Smith and Nephew Business Overview
Table 89. Smith and Nephew Recent Developments
Table 90. Yangtze River Pharmaceutical Group Basic Information
Table 91. Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Overview
Table 92. Yangtze River Pharmaceutical Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Yangtze River Pharmaceutical Group Business Overview
Table 94. Yangtze River Pharmaceutical Group Recent Developments
Table 95. STADA Thornton and Ross Basic Information
Table 96. STADA Thornton and Ross Burn and Scald Medicine Product Overview
Table 97. STADA Thornton and Ross Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. STADA Thornton and Ross Business Overview
Table 99. STADA Thornton and Ross Recent Developments
Table 100. Kenvue Brands LLC Basic Information
Table 101. Kenvue Brands LLC Burn and Scald Medicine Product Overview
Table 102. Kenvue Brands LLC Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Kenvue Brands LLC Business Overview
Table 104. Kenvue Brands LLC Recent Developments
Table 105. Changchun Overseas Pharmaceutical Group Co., Ltd. Basic Information
Table 106. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Overview
Table 107. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Changchun Overseas Pharmaceutical Group Co., Ltd. Business Overview
Table 109. Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments
Table 110. Orkla Health Basic Information
Table 111. Orkla Health Burn and Scald Medicine Product Overview
Table 112. Orkla Health Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Orkla Health Business Overview
Table 114. Orkla Health Recent Developments
Table 115. Guangdong Hengjian Pharmaceutical Basic Information
Table 116. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Overview
Table 117. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Guangdong Hengjian Pharmaceutical Business Overview
Table 119. Guangdong Hengjian Pharmaceutical Recent Developments
Table 120. Otsuka Pharmaceutical Co., Ltd. Basic Information
Table 121. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
Table 122. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Otsuka Pharmaceutical Co., Ltd. Business Overview
Table 124. Otsuka Pharmaceutical Co., Ltd. Recent Developments
Table 125. Tonghua Maoxiang Pharmaceutical Co., Ltd. Basic Information
Table 126. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
Table 127. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Tonghua Maoxiang Pharmaceutical Co., Ltd. Business Overview
Table 129. Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments
Table 130. Cipla Basic Information
Table 131. Cipla Burn and Scald Medicine Product Overview
Table 132. Cipla Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Cipla Business Overview
Table 134. Cipla Recent Developments
Table 135. Tanabe Mitsubishi Pharmaceuticals Basic Information
Table 136. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Overview
Table 137. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Tanabe Mitsubishi Pharmaceuticals Business Overview
Table 139. Tanabe Mitsubishi Pharmaceuticals Recent Developments
Table 140. Chongqing Xixuan Biotechnology Co., Ltd. Basic Information
Table 141. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Overview
Table 142. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Chongqing Xixuan Biotechnology Co., Ltd. Business Overview
Table 144. Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments
Table 145. Quest Products, LLC Basic Information
Table 146. Quest Products, LLC Burn and Scald Medicine Product Overview
Table 147. Quest Products, LLC Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Quest Products, LLC Business Overview
Table 149. Quest Products, LLC Recent Developments
Table 150. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Basic Information
Table 151. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Overview
Table 152. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Business Overview
Table 154. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments
Table 155. Acme United Corp. Basic Information
Table 156. Acme United Corp. Burn and Scald Medicine Product Overview
Table 157. Acme United Corp. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Acme United Corp. Business Overview
Table 159. Acme United Corp. Recent Developments
Table 160. Dongwha Pharm Basic Information
Table 161. Dongwha Pharm Burn and Scald Medicine Product Overview
Table 162. Dongwha Pharm Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Dongwha Pharm Business Overview
Table 164. Dongwha Pharm Recent Developments
Table 165. China Resources Pharmaceutical Group Basic Information
Table 166. China Resources Pharmaceutical Group Burn and Scald Medicine Product Overview
Table 167. China Resources Pharmaceutical Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. China Resources Pharmaceutical Group Business Overview
Table 169. China Resources Pharmaceutical Group Recent Developments
Table 170. Safetec Of America Basic Information
Table 171. Safetec Of America Burn and Scald Medicine Product Overview
Table 172. Safetec Of America Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Safetec Of America Business Overview
Table 174. Safetec Of America Recent Developments
Table 175. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Basic Information
Table 176. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
Table 177. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Business Overview
Table 179. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments
Table 180. North China Pharmaceutical Hebei Huanuo Basic Information
Table 181. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Overview
Table 182. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. North China Pharmaceutical Hebei Huanuo Business Overview
Table 184. North China Pharmaceutical Hebei Huanuo Recent Developments
Table 185. Xiangxi Hongcheng Pharmaceutical Basic Information
Table 186. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Overview
Table 187. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Xiangxi Hongcheng Pharmaceutical Business Overview
Table 189. Xiangxi Hongcheng Pharmaceutical Recent Developments
Table 190. Hebei Aoxing Group Pharmaceuticals Basic Information
Table 191. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Overview
Table 192. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 193. Hebei Aoxing Group Pharmaceuticals Business Overview
Table 194. Hebei Aoxing Group Pharmaceuticals Recent Developments
Table 195. Jilin Aodong Pharmaceutical Group Basic Information
Table 196. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Overview
Table 197. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 198. Jilin Aodong Pharmaceutical Group Business Overview
Table 199. Jilin Aodong Pharmaceutical Group Recent Developments
Table 200. Beijing Tongrentang Basic Information
Table 201. Beijing Tongrentang Burn and Scald Medicine Product Overview
Table 202. Beijing Tongrentang Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 203. Beijing Tongrentang Business Overview
Table 204. Beijing Tongrentang Recent Developments
Table 205. Henan Quanyu Pharmaceuticals Basic Information
Table 206. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Overview
Table 207. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 208. Henan Quanyu Pharmaceuticals Business Overview
Table 209. Henan Quanyu Pharmaceuticals Recent Developments
Table 210. Chengdu First Pharmaceuticals Basic Information
Table 211. Chengdu First Pharmaceuticals Burn and Scald Medicine Product Overview
Table 212. Chengdu First Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 213. Chengdu First Pharmaceuticals Business Overview
Table 214. Chengdu First Pharmaceuticals Recent Developments
Table 215. Global Burn and Scald Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 216. Global Burn and Scald Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 217. North America Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 218. North America Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 219. Europe Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 220. Europe Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 221. Asia Pacific Burn and Scald Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 222. Asia Pacific Burn and Scald Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 223. South America Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 224. South America Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 225. Middle East and Africa Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 226. Middle East and Africa Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 227. Global Burn and Scald Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 228. Global Burn and Scald Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 229. Global Burn and Scald Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 230. Global Burn and Scald Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 231. Global Burn and Scald Medicine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Burn and Scald Medicine Market Size by Type (M USD)
Table 4. Global Burn and Scald Medicine Market Size by Application
Table 5. Burn and Scald Medicine Market Size Comparison by Region (M USD)
Table 6. Global Burn and Scald Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Burn and Scald Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Burn and Scald Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Burn and Scald Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burn and Scald Medicine as of 2025)
Table 11. Global Market Burn and Scald Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Burn and Scald Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Burn and Scald Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Burn and Scald Medicine Sales by Type (K MT)
Table 27. Global Burn and Scald Medicine Market Size by Type (M USD)
Table 28. Global Burn and Scald Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Burn and Scald Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Burn and Scald Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Burn and Scald Medicine Market Share by Type (2020-2025)
Table 32. Global Burn and Scald Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Burn and Scald Medicine Sales (K MT) by Application
Table 34. Global Burn and Scald Medicine Market Size by Application
Table 35. Global Burn and Scald Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Burn and Scald Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Burn and Scald Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Burn and Scald Medicine Market Share by Application (2020-2025)
Table 39. Global Burn and Scald Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Burn and Scald Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Burn and Scald Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Burn and Scald Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Burn and Scald Medicine Market Size by Region (2020-2025)
Table 44. North America Burn and Scald Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Burn and Scald Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Burn and Scald Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Burn and Scald Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Burn and Scald Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Burn and Scald Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Burn and Scald Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Burn and Scald Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Burn and Scald Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Burn and Scald Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Burn and Scald Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Burn and Scald Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Burn and Scald Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Burn and Scald Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Mebao Pharmaceutical Technology Group Basic Information
Table 63. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Overview
Table 64. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Mebao Pharmaceutical Technology Group Business Overview
Table 66. Mebao Pharmaceutical Technology Group SWOT Analysis
Table 67. Mebao Pharmaceutical Technology Group Recent Developments
Table 68. B. Braun Basic Information
Table 69. B. Braun Burn and Scald Medicine Product Overview
Table 70. B. Braun Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. B. Braun Business Overview
Table 72. B. Braun SWOT Analysis
Table 73. B. Braun Recent Developments
Table 74. Integra LifeSciences Basic Information
Table 75. Integra LifeSciences Burn and Scald Medicine Product Overview
Table 76. Integra LifeSciences Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Integra LifeSciences Business Overview
Table 78. Integra LifeSciences SWOT Analysis
Table 79. Integra LifeSciences Recent Developments
Table 80. Jinyao Darentang Basic Information
Table 81. Jinyao Darentang Burn and Scald Medicine Product Overview
Table 82. Jinyao Darentang Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Jinyao Darentang Business Overview
Table 84. Jinyao Darentang Recent Developments
Table 85. Smith and Nephew Basic Information
Table 86. Smith and Nephew Burn and Scald Medicine Product Overview
Table 87. Smith and Nephew Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Smith and Nephew Business Overview
Table 89. Smith and Nephew Recent Developments
Table 90. Yangtze River Pharmaceutical Group Basic Information
Table 91. Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Overview
Table 92. Yangtze River Pharmaceutical Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Yangtze River Pharmaceutical Group Business Overview
Table 94. Yangtze River Pharmaceutical Group Recent Developments
Table 95. STADA Thornton and Ross Basic Information
Table 96. STADA Thornton and Ross Burn and Scald Medicine Product Overview
Table 97. STADA Thornton and Ross Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. STADA Thornton and Ross Business Overview
Table 99. STADA Thornton and Ross Recent Developments
Table 100. Kenvue Brands LLC Basic Information
Table 101. Kenvue Brands LLC Burn and Scald Medicine Product Overview
Table 102. Kenvue Brands LLC Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Kenvue Brands LLC Business Overview
Table 104. Kenvue Brands LLC Recent Developments
Table 105. Changchun Overseas Pharmaceutical Group Co., Ltd. Basic Information
Table 106. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Overview
Table 107. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Changchun Overseas Pharmaceutical Group Co., Ltd. Business Overview
Table 109. Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments
Table 110. Orkla Health Basic Information
Table 111. Orkla Health Burn and Scald Medicine Product Overview
Table 112. Orkla Health Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Orkla Health Business Overview
Table 114. Orkla Health Recent Developments
Table 115. Guangdong Hengjian Pharmaceutical Basic Information
Table 116. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Overview
Table 117. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Guangdong Hengjian Pharmaceutical Business Overview
Table 119. Guangdong Hengjian Pharmaceutical Recent Developments
Table 120. Otsuka Pharmaceutical Co., Ltd. Basic Information
Table 121. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
Table 122. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Otsuka Pharmaceutical Co., Ltd. Business Overview
Table 124. Otsuka Pharmaceutical Co., Ltd. Recent Developments
Table 125. Tonghua Maoxiang Pharmaceutical Co., Ltd. Basic Information
Table 126. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
Table 127. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Tonghua Maoxiang Pharmaceutical Co., Ltd. Business Overview
Table 129. Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments
Table 130. Cipla Basic Information
Table 131. Cipla Burn and Scald Medicine Product Overview
Table 132. Cipla Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Cipla Business Overview
Table 134. Cipla Recent Developments
Table 135. Tanabe Mitsubishi Pharmaceuticals Basic Information
Table 136. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Overview
Table 137. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Tanabe Mitsubishi Pharmaceuticals Business Overview
Table 139. Tanabe Mitsubishi Pharmaceuticals Recent Developments
Table 140. Chongqing Xixuan Biotechnology Co., Ltd. Basic Information
Table 141. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Overview
Table 142. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Chongqing Xixuan Biotechnology Co., Ltd. Business Overview
Table 144. Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments
Table 145. Quest Products, LLC Basic Information
Table 146. Quest Products, LLC Burn and Scald Medicine Product Overview
Table 147. Quest Products, LLC Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Quest Products, LLC Business Overview
Table 149. Quest Products, LLC Recent Developments
Table 150. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Basic Information
Table 151. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Overview
Table 152. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Business Overview
Table 154. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments
Table 155. Acme United Corp. Basic Information
Table 156. Acme United Corp. Burn and Scald Medicine Product Overview
Table 157. Acme United Corp. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Acme United Corp. Business Overview
Table 159. Acme United Corp. Recent Developments
Table 160. Dongwha Pharm Basic Information
Table 161. Dongwha Pharm Burn and Scald Medicine Product Overview
Table 162. Dongwha Pharm Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Dongwha Pharm Business Overview
Table 164. Dongwha Pharm Recent Developments
Table 165. China Resources Pharmaceutical Group Basic Information
Table 166. China Resources Pharmaceutical Group Burn and Scald Medicine Product Overview
Table 167. China Resources Pharmaceutical Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. China Resources Pharmaceutical Group Business Overview
Table 169. China Resources Pharmaceutical Group Recent Developments
Table 170. Safetec Of America Basic Information
Table 171. Safetec Of America Burn and Scald Medicine Product Overview
Table 172. Safetec Of America Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Safetec Of America Business Overview
Table 174. Safetec Of America Recent Developments
Table 175. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Basic Information
Table 176. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Overview
Table 177. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Business Overview
Table 179. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments
Table 180. North China Pharmaceutical Hebei Huanuo Basic Information
Table 181. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Overview
Table 182. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. North China Pharmaceutical Hebei Huanuo Business Overview
Table 184. North China Pharmaceutical Hebei Huanuo Recent Developments
Table 185. Xiangxi Hongcheng Pharmaceutical Basic Information
Table 186. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Overview
Table 187. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Xiangxi Hongcheng Pharmaceutical Business Overview
Table 189. Xiangxi Hongcheng Pharmaceutical Recent Developments
Table 190. Hebei Aoxing Group Pharmaceuticals Basic Information
Table 191. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Overview
Table 192. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 193. Hebei Aoxing Group Pharmaceuticals Business Overview
Table 194. Hebei Aoxing Group Pharmaceuticals Recent Developments
Table 195. Jilin Aodong Pharmaceutical Group Basic Information
Table 196. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Overview
Table 197. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 198. Jilin Aodong Pharmaceutical Group Business Overview
Table 199. Jilin Aodong Pharmaceutical Group Recent Developments
Table 200. Beijing Tongrentang Basic Information
Table 201. Beijing Tongrentang Burn and Scald Medicine Product Overview
Table 202. Beijing Tongrentang Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 203. Beijing Tongrentang Business Overview
Table 204. Beijing Tongrentang Recent Developments
Table 205. Henan Quanyu Pharmaceuticals Basic Information
Table 206. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Overview
Table 207. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 208. Henan Quanyu Pharmaceuticals Business Overview
Table 209. Henan Quanyu Pharmaceuticals Recent Developments
Table 210. Chengdu First Pharmaceuticals Basic Information
Table 211. Chengdu First Pharmaceuticals Burn and Scald Medicine Product Overview
Table 212. Chengdu First Pharmaceuticals Burn and Scald Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 213. Chengdu First Pharmaceuticals Business Overview
Table 214. Chengdu First Pharmaceuticals Recent Developments
Table 215. Global Burn and Scald Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 216. Global Burn and Scald Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 217. North America Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 218. North America Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 219. Europe Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 220. Europe Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 221. Asia Pacific Burn and Scald Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 222. Asia Pacific Burn and Scald Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 223. South America Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 224. South America Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 225. Middle East and Africa Burn and Scald Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 226. Middle East and Africa Burn and Scald Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 227. Global Burn and Scald Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 228. Global Burn and Scald Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 229. Global Burn and Scald Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 230. Global Burn and Scald Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 231. Global Burn and Scald Medicine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Burn and Scald Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Burn and Scald Medicine Market Size (M USD), 2025-2035
Figure 5. Global Burn and Scald Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Burn and Scald Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Burn and Scald Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Burn and Scald Medicine Product Life Cycle
Figure 13. Burn and Scald Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Burn and Scald Medicine Revenue Share by Manufacturers in 2025
Figure 15. Burn and Scald Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Burn and Scald Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Burn and Scald Medicine Revenue in 2025
Figure 18. Industry Chain Map of Burn and Scald Medicine
Figure 19. Global Burn and Scald Medicine Market PEST Analysis
Figure 20. Global Burn and Scald Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Burn and Scald Medicine Market Share by Type
Figure 27. Sales Market Share of Burn and Scald Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Burn and Scald Medicine by Type in 2025
Figure 29. Market Share of Burn and Scald Medicine by Type (2020-2025)
Figure 30. Market Share of Burn and Scald Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Burn and Scald Medicine Market Share by Application
Figure 33. Global Burn and Scald Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Burn and Scald Medicine Sales Market Share by Application in 2025
Figure 35. Global Burn and Scald Medicine Market Share by Application (2020-2025)
Figure 36. Global Burn and Scald Medicine Market Share by Application in 2025
Figure 37. Global Burn and Scald Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Burn and Scald Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Burn and Scald Medicine Market Size by Region (2020-2025)
Figure 40. North America Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Burn and Scald Medicine Sales Market Share by Country in 2024
Figure 43. North America Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Burn and Scald Medicine Market Size by Country in 2024
Figure 45. U.S. Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Burn and Scald Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Burn and Scald Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Burn and Scald Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Burn and Scald Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Burn and Scald Medicine Sales Market Share by Country in 2024
Figure 53. Europe Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Burn and Scald Medicine Market Size by Country in 2024
Figure 55. Germany Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Burn and Scald Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Burn and Scald Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Burn and Scald Medicine Market Size by Region in 2024
Figure 68. China Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Burn and Scald Medicine Sales and Growth Rate (K MT)
Figure 79. South America Burn and Scald Medicine Sales Market Share by Country in 2024
Figure 80. South America Burn and Scald Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Burn and Scald Medicine Market Size by Country in 2024
Figure 82. Brazil Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Burn and Scald Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Burn and Scald Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Burn and Scald Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Burn and Scald Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Burn and Scald Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Burn and Scald Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Burn and Scald Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Burn and Scald Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Burn and Scald Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Burn and Scald Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Burn and Scald Medicine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Burn and Scald Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Burn and Scald Medicine Market Size (M USD), 2025-2035
Figure 5. Global Burn and Scald Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Burn and Scald Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Burn and Scald Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Burn and Scald Medicine Product Life Cycle
Figure 13. Burn and Scald Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Burn and Scald Medicine Revenue Share by Manufacturers in 2025
Figure 15. Burn and Scald Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Burn and Scald Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Burn and Scald Medicine Revenue in 2025
Figure 18. Industry Chain Map of Burn and Scald Medicine
Figure 19. Global Burn and Scald Medicine Market PEST Analysis
Figure 20. Global Burn and Scald Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Burn and Scald Medicine Market Share by Type
Figure 27. Sales Market Share of Burn and Scald Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Burn and Scald Medicine by Type in 2025
Figure 29. Market Share of Burn and Scald Medicine by Type (2020-2025)
Figure 30. Market Share of Burn and Scald Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Burn and Scald Medicine Market Share by Application
Figure 33. Global Burn and Scald Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Burn and Scald Medicine Sales Market Share by Application in 2025
Figure 35. Global Burn and Scald Medicine Market Share by Application (2020-2025)
Figure 36. Global Burn and Scald Medicine Market Share by Application in 2025
Figure 37. Global Burn and Scald Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Burn and Scald Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Burn and Scald Medicine Market Size by Region (2020-2025)
Figure 40. North America Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Burn and Scald Medicine Sales Market Share by Country in 2024
Figure 43. North America Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Burn and Scald Medicine Market Size by Country in 2024
Figure 45. U.S. Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Burn and Scald Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Burn and Scald Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Burn and Scald Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Burn and Scald Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Burn and Scald Medicine Sales Market Share by Country in 2024
Figure 53. Europe Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Burn and Scald Medicine Market Size by Country in 2024
Figure 55. Germany Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Burn and Scald Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Burn and Scald Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Burn and Scald Medicine Market Size by Region in 2024
Figure 68. China Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Burn and Scald Medicine Sales and Growth Rate (K MT)
Figure 79. South America Burn and Scald Medicine Sales Market Share by Country in 2024
Figure 80. South America Burn and Scald Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Burn and Scald Medicine Market Size by Country in 2024
Figure 82. Brazil Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Burn and Scald Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Burn and Scald Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Burn and Scald Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Burn and Scald Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Burn and Scald Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Burn and Scald Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Burn and Scald Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Burn and Scald Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Burn and Scald Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Burn and Scald Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Burn and Scald Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Burn and Scald Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Burn and Scald Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Burn and Scald Medicine Market Share Forecast by Application (2026-2035)
